We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.
Blog post branding logo

Medcast makes a new home for quality use of medicines education

25 March 2024 - Quality Use of Medicines Alliance

Medcast has launched QHUB, an innovative new platform dedicated to quality use of medicines education. The initiative marks a significant milestone for the Quality Use of Medicines Alliance - a consortium spearheaded by Medcast and Health Care Consumers Association and funded by the Australian Government through the Quality use of Diagnostics, Therapeutics and Pathology Program.

QHUB represents one of the most substantial quality use of medicines education initiatives since the discontinuation of NPS MedicineWise in 2022. 

Over the next 2 years QHUB will provide invaluable support to healthcare professionals across 4 priority health areas, with an initial focus on eczema, followed by gout, antidepressants in older people and anticoagulants. 

A pivotal resource, QHUB will empower health professionals to enhance patient outcomes. It offers a comprehensive range of free, innovative, evidence-informed activities and resources including virtual educational visits, live webinars, podcasts, peer group learning and health professional mediated consumer resources.

 A/Prof Dr Stephen Barnett Managing Director at Medcast

Facilitated through the Quality Use of Medicines Alliance, QHUB brings together quality use of medicines expertise, researchers, education providers, colleges, peak bodies and consumer groups. This collaborative approach emphasises the integration of consumer and healthcare professional perspectives at every stage of development.

Darlene Cox, Executive Director at Health Care Consumers Association highlighted the program's co-design principles and said 

‘This program exemplifies co-design in action, with consumers and healthcare professionals collaborating to design, develop, and deliver evidence-based resources to improve health outcomes for consumers and carers’.


QHUB’s launch is timely, commencing with a focus on eczema, a condition affecting approximately 2.8 million Australians including 1 in 3 children aged under 6. Despite being often perceived as a minor ailment, eczema poses significant challenges for patients, impacting their quality of life and mental well-being. Moreover, the condition incurs substantial costs to the healthcare system, exceeding $593 million in 2019-2020¹. 

Patients and carers encounter inconsistent information from different health professionals, which leaves them confused, less likely to adhere to foundational and first-line therapy, and more open to information from less reliable sources, such as social media. And with health professionals facing limited time and ready access to supporting resources for eczema, there can be significant variations in practice and communication with patients.

The launch of QHUB signifies a crucial step towards addressing quality use of medicines challenges and fostering collaboration between healthcare professionals and consumers.

For media inquiries and further information, please contact: 

Kate Clutton
M: 0407 580 929



Quality Use of Medicines Alliance
Quality Use of Medicines Alliance

The Quality Use of Medicines Alliance a consortium of eight health and consumer organisations, will align their work across the two grants, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.  


Receive QHUB updates to your inbox.

Or follow us on social media

Related Tags
Related Categories
Latest News
Optimising paediatric Eczema Care: A Nurses’ Guide
Brand icon

Explore essential strategies and insights for managing paediatric eczema effectively in this guide. From daily skincare routines to addressing common triggers and mental health considerations, empower families with the knowledge and tools to improve their child's quality of life.

5 mins READ
Men’s health behaviours - Clinical opal

Gender influences individuals’ health behaviours and their use of health services. This translates into a high burden of disease in males due to the contribution of modifiable risk factors. Helping men understand how their behaviour influences their health, and what they can do to change it, may help them to live longer, healthier lives.

5 mins READ
Medcast Partners with the University of Wollongong to Combat Antimicrobial Resistance

Medcast is thrilled to announce a new collaboration with the University of Wollongong’s Graduate School of Medicine. The $2.7M MRFF grant focuses on reducing the inappropriate prescription of antibiotics, a key factor in the development of antimicrobial resistance (AMR).